You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-myeloablative transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

Active, not recruiting
  • Mycoses
  • +5 more
  • anti-thymocyte globulin
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
Jun 16, 2022

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against

Not yet recruiting
  • HPV 16+ Recurrent or Metastatic Cancer
  • CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
  • Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
  • (no location specified)
Jun 27, 2022

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

Kidney Transplantation Trial in Baltimore, Livingston, New York (TCD601)

Recruiting
  • Kidney Transplantation
  • TCD601
  • San Francisco, California
  • +4 more
Oct 28, 2022

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Stanford (biological, drug,

Completed
Has Results
  • Acute Myeloid Leukemia
  • +6 more
  • Anti-Thymocyte Globulin
  • +5 more
  • Stanford, California
    Stanford University, School of Medicine
Jun 1, 2021

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
Has Results
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical

Not yet recruiting
  • Sickle Cell Disease
  • Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

Completed
  • Severe Aplastic Anemia
  • Bone Marrow Failure Syndromes
  • Bone marrow transplant
  • +7 more
  • Baltimore, Maryland
  • +1 more
Feb 10, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Acute Leukemia
  • +24 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 4, 2021

B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

Recruiting
  • B-cell Lymphoma
  • +8 more
  • Polatuzumab vedotin
  • Valhalla, New York
    New York Medical Center
Oct 29, 2021

Multiple Myeloma Trial in United States (procedure, drug, behavioral)

Completed
Has Results
  • Multiple Myeloma
  • One Autologous Transplant
  • +5 more
  • Birmingham, Alabama
  • +35 more
Oct 19, 2021

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Lymphoma, Non-Hodgkin Trial in United States (Hematopoietic Stem Cell Transplant)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Hematopoietic Stem Cell Transplant
  • Duarte, California
  • +20 more
Dec 7, 2021

Single Umbilical Cord Blood Transplantation, Non-myeloablative Conditioning, Acute Lymphocytic Leukemia Trial in Minneapolis

Completed
Has Results
  • Single Umbilical Cord Blood Transplantation
  • +6 more
  • Minneapolis, Minnesota
    Novartis Investigative Site
Dec 9, 2020

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

Recruiting
  • Leukemia, Myeloid, Acute
  • +5 more
  • Melbourne, Victoria, Australia
    Melbourne Health
Jun 19, 2022

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

Completed
Has Results
  • Myeloproliferative Disorders
  • +3 more
  • anti-thymocyte globulin
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Oct 30, 2020

Hematologic Malignancies Trial in Lebanon (Stem Cell Transplant, G-CSF, Fludarabine)

Completed
Has Results
  • Hematologic Malignancies
  • Stem Cell Transplant
  • +5 more
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Oct 30, 2020

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical

Active, not recruiting
  • Hodgkin's Lymphoma
  • +8 more
  • Reduced intensity haplodentical stem cell transplant
  • Myeloablative haploidentical stem cell transplant
  • Birmingham, United Kingdom
  • +11 more
Sep 27, 2021

Multiple Myeloma Trial in Worldwide (HLA Matched allogeneic transplant)

Completed
  • Multiple Myeloma
  • HLA Matched allogeneic transplant
  • Wien, Austria
  • +23 more
Oct 5, 2021

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022